Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Usana Health Sciences (USNA) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Usana Health Sciences (USNA) over the last 15 years, with Q3 2025 value amounting to 0.07%.

  • Usana Health Sciences' Return on Capital Employed fell 900.0% to 0.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07%, marking a year-over-year decrease of 900.0%. This contributed to the annual value of 0.12% for FY2024, which is 700.0% down from last year.
  • Per Usana Health Sciences' latest filing, its Return on Capital Employed stood at 0.07% for Q3 2025, which was down 900.0% from 0.09% recorded in Q2 2025.
  • Over the past 5 years, Usana Health Sciences' Return on Capital Employed peaked at 0.44% during Q1 2022, and registered a low of 0.07% during Q3 2025.
  • Moreover, its 5-year median value for Return on Capital Employed was 0.2% (2023), whereas its average is 0.24%.
  • In the last 5 years, Usana Health Sciences' Return on Capital Employed skyrocketed by 500bps in 2022 and then plummeted by -2000bps in 2023.
  • Over the past 5 years, Usana Health Sciences' Return on Capital Employed (Quarter) stood at 0.43% in 2021, then crashed by -42bps to 0.25% in 2022, then dropped by -25bps to 0.19% in 2023, then tumbled by -38bps to 0.12% in 2024, then crashed by -41bps to 0.07% in 2025.
  • Its Return on Capital Employed was 0.07% in Q3 2025, compared to 0.09% in Q2 2025 and 0.09% in Q1 2025.